Gout Medication at the Right Dose May Slash Heart Attack and Stroke Risks

A new study suggests that the correct dose of gout medication could do more than ease joint pain—it may also cut the risk of heart attacks and strokes. Researchers at the University of Nottingham found that lowering urate levels in the blood with drugs like allopurinol reduces cardiovascular risks in patients with gout.

Gout is a type of inflammatory arthritis that causes sudden pain and swelling in joints. Over time, high urate levels can form sharp crystals around joints, leading to flare-ups. The condition affects men and older adults more often, with Asian-Americans seeing the fastest rise in cases recently.

Allopurinol, a widely used gout treatment, has long been known to manage symptoms. But new research shows it may also protect against heart disease if taken at the right dose. Patients with serum urate levels below 360 micromol/L experienced fewer gout attacks and a lower risk of cardiovascular problems.

The Nottingham team, led by Professor Abhishek, went further. They found the greatest benefits in patients who reached a level below 300 µmol/L. This target is stricter than current guidelines, which recommend staying under 360 µmol/L. Those who hit the lower threshold within a year of treatment had better five-year survival rates and fewer major heart events.

However, the ideal dose of allopurinol varies between individuals. Adjusting it carefully could make a significant difference in both managing gout and protecting heart health.

The findings highlight the importance of precise medication dosing for gout patients. Achieving lower urate levels not only reduces flare-ups but also lowers the risk of life-threatening cardiovascular events. Doctors may now consider stricter targets when prescribing allopurinol to maximise these benefits.